China · Delayed Price · Currency is CNY Wuhan Hvsen Biotechnology Statistics
Total Valuation
SHE:300871 has a market cap or net worth of CNY 3.55 billion. The enterprise value is 3.60 billion.
| Market Cap | 3.55B |
| Enterprise Value | 3.60B |
Important Dates
The last earnings date was Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | Sep 8, 2026 |
Share Statistics
SHE:300871 has 200.41 million shares outstanding. The number of shares has increased by 15.44% in one year.
| Current Share Class | 200.41M |
| Shares Outstanding | 200.41M |
| Shares Change (YoY) | +15.44% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 5.56% |
| Owned by Institutions (%) | 7.55% |
| Float | 104.38M |
Valuation Ratios
The trailing PE ratio is 11.39 and the forward PE ratio is 15.67.
| PE Ratio | 11.39 |
| Forward PE | 15.67 |
| PS Ratio | 2.08 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.84 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 11.11 |
| EV / Sales | 2.11 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 11.83 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.09 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | n/a |
| Interest Coverage | 96.22 |
Financial Efficiency
Return on equity (ROE) is 14.65% and return on invested capital (ROIC) is 11.81%.
| Return on Equity (ROE) | 14.65% |
| Return on Assets (ROA) | 5.98% |
| Return on Invested Capital (ROIC) | 11.81% |
| Return on Capital Employed (ROCE) | 11.15% |
| Weighted Average Cost of Capital (WACC) | 7.02% |
| Revenue Per Employee | 1.51M |
| Profits Per Employee | 286,045 |
| Employee Count | 1,133 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 3.98 |
Taxes
In the past 12 months, SHE:300871 has paid 41.19 million in taxes.
| Income Tax | 41.19M |
| Effective Tax Rate | 11.25% |
Stock Price Statistics
The stock price has decreased by -18.01% in the last 52 weeks. The beta is 0.67, so SHE:300871's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -18.01% |
| 50-Day Moving Average | 20.61 |
| 200-Day Moving Average | 23.50 |
| Relative Strength Index (RSI) | 39.04 |
| Average Volume (20 Days) | 4,195,451 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300871 had revenue of CNY 1.71 billion and earned 324.09 million in profits. Earnings per share was 1.55.
| Revenue | 1.71B |
| Gross Profit | 581.51M |
| Operating Income | 304.37M |
| Pretax Income | 366.29M |
| Net Income | 324.09M |
| EBITDA | 429.94M |
| EBIT | 304.37M |
| Earnings Per Share (EPS) | 1.55 |
Balance Sheet
The company has 476.83 million in cash and 515.40 million in debt, with a net cash position of -38.56 million or -0.19 per share.
| Cash & Cash Equivalents | 476.83M |
| Total Debt | 515.40M |
| Net Cash | -38.56M |
| Net Cash Per Share | -0.19 |
| Equity (Book Value) | 2.32B |
| Book Value Per Share | 11.51 |
| Working Capital | 728.75M |
Cash Flow
In the last 12 months, operating cash flow was 256.38 million and capital expenditures -419.83 million, giving a free cash flow of -163.45 million.
| Operating Cash Flow | 256.38M |
| Capital Expenditures | -419.83M |
| Depreciation & Amortization | 125.57M |
| Net Borrowing | 218.11M |
| Free Cash Flow | -163.45M |
| FCF Per Share | -0.82 |
Margins
Gross margin is 34.08%, with operating and profit margins of 17.84% and 18.99%.
| Gross Margin | 34.08% |
| Operating Margin | 17.84% |
| Pretax Margin | 21.47% |
| Profit Margin | 18.99% |
| EBITDA Margin | 25.20% |
| EBIT Margin | 17.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 3.39%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 3.39% |
| Dividend Growth (YoY) | 142.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 32.98% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.44% |
| Shareholder Yield | -12.06% |
| Earnings Yield | 8.78% |
| FCF Yield | -4.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 10, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | May 10, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300871 has an Altman Z-Score of 3.95 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.95 |
| Piotroski F-Score | 5 |